BARRE, Tangui; ROJAS ROJAS, Teresa; LACOMBE, Karine; PROTOPOPESCU, Camelia; POIZOT-MARTIN, Isabelle; NISHIMWE, Marie; ZUCMAN, David; ESTERLE, Laure; BILLAUD, Eric; AUMAITRE, Hugues; BOUCHAUD, Olivier; REY, David; PIROTH, Lionel; SALMON-CERON, Dominique; WITTKOP, Linda; SOGNI, Philippe; CARRIERI, Maria Patrizia; SERFATY, Lawrence; MARCELLIN, Fabienne

doi:10.1080/14787210.2021.1884545

Métadonnées

Afficher la notice complète

Licence d’utilisation du document

Langue

Article de revue

Ce document a été publié dans

Expert Review of Anti-infective Therapy. 2021-02-04p. 1-10

Résumé en anglais

Background: Cannabis use and elevated fatty liver index (FLI≥ 60) (a biomarker of hepatic steatosis in the general population) have been identified as predictors of HCV-related and overall mortality, respectively, in HIV-HCV co-infected patients. However, the relationship between cannabis use and the risk of elevated FLI has never been explored. Methods: Using five-year follow-up data from 997 HIV-HCV co-infected patients (ANRS CO13 HEPAVIH cohort), we analyzed the relationship between cannabis use and FLI using mixed-effects multivariable logistic (outcome: elevated FLI yes/no) and linear (outcome: continuous FLI) regression models. Results: At the last follow-up visit, 27.4% of patients reported regular or daily cannabis use and 27.8% had elevated FLI. After multivariable adjustment, regular or daily cannabis use was associated with a 55% lower risk of elevated FLI (adjusted odds ratio [95% confidence interval]: 0.45 [0.22; 0.94]; p = 0.033) and lower FLI values (adjusted model coefficient: -4.24 [-6.57; -1.91], p<0.0001). Conclusions: Cannabis use is associated with a reduced risk of elevated fatty liver index in HIV-HCV co-infected patients. Further research is needed to confirm whether and how cannabinoids may inhibit the development of hepatic steatosis or other metabolic disorders in high-risk populations.< Réduire

Mots clés en anglais

Cannabis

Hepatitis C

Chronic

Human immunodeficiency virus

Fatty liver

Metabolic diseases

Métadonnées

Partager cette publication !

Licence d’utilisation du document

Cannabis use and reduced risk of elevated fatty liver index in HIV-HCV co-infected patients: a longitudinal analysis (ANRS CO13 HEPAVIH)

Langue

Ce document a été publié dans

Résumé en anglais

Mots clés en anglais

URI

DOI

Unités de recherche